Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX HELSINKI LTD.  >  Oriola Oyj    OKDBV   FI0009014351

ORIOLA OYJ (OKDBV)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Helsinki Ltd.
12/05/2017 12/07/2017 12/08/2017 12/11/2017 12/12/2017 Date
2.9(c) 2.86(c) 2.87(c) 2.9(c) 2.93 Last
288 568 157 024 316 819 290 951 224 169 Volume
-3.33% -1.38% +0.35% +1.05% +1.03% Change
More quotes
Financials (€)
Sales 2017 1 568 M
EBIT 2017 45,4 M
Net income 2017 32,3 M
Debt 2017 67,7 M
Yield 2017 4,76%
Sales 2018 1 607 M
EBIT 2018 53,6 M
Net income 2018 38,3 M
Debt 2018 60,2 M
Yield 2018 5,45%
P/E ratio 2017 16,29
P/E ratio 2018 13,55
EV / Sales2017 0,39x
EV / Sales2018 0,37x
Capitalization 539 M
More Financials
Company
Oriola Corp. engages in the provision of pharmaceutical, and health and well-being products retail and wholesale.The company provides a wide service offering covering pharmaceutical distribution, branded products, and other tailored services.It operates through the following segments: Consumer,... 
Sector
Drug Retailers
Calendar
02/13Earnings Release
More about the company
Surperformance© ratings of Oriola Oyj
Trading Rating : Investor Rating :
More Ratings
Latest news on ORIOLA OYJ
12/11 ORIOLA OYJ : The Finnish Pharmacy Days 2017 reached over 6000 visitors
12/08 ORIOLA OYJ : starts cooperation with online medical center Doktor.se in Sweden
12/04 ORIOLA OYJ : Mobile application supports medication
11/29 ORIOLA OYJ : Publication schedule for Oriola Corporation's financial reporting i..
11/15 ORIOLA OYJ : Hehku is Oriola and Kesko’s new store chain specialising in w..
11/10 ORIOLA OYJ : Corporation - Managers' transactions
10/25 ORIOLA OYJ : Corporation’s Interim Report January-September 2017
10/25 ORIOLA OYJ : Corporation's Interim Report January-September 2017
10/19 ORIOLA OYJ : has completed the sale of its Baltic businesses
10/12 ORIOLA OYJ : Corporation’s third quarter result impacted by distribution d..
More news
Sector news : Retail - Drugs without Grocery
12/08 CVS expects U.S. Justice Department to handle review of Aetna deal
12/06DJWALGREENS BOOTS ALLIANCE : Takes Stake in Chinese Pharmacy Chain
12/05 CVS likely wants FTC antitrust review, not Justice Dept, of Aetna deal
12/05 CVS likely wants FTC antitrust review, not Justice Department, of Aetna deal
12/04 CVS, Aetna executives defend $69 billion deal to skeptical Wall Street
More sector news : Retail - Drugs without Grocery
Chart ORIOLA OYJ
Duration : Period :
Oriola Oyj Technical Analysis Chart | OKDBV | FI0009014351 | 4-Traders
Technical analysis trends ORIOLA OYJ
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Average target price 3,62 €
Spread / Average Target 25%
EPS Revisions
Managers
NameTitle
Eero Ilmari Hautaniemi President & Chief Executive Officer
Anssi Markku Kaleva Vanjoki Chairman
Sari Aitokallio Chief Financial Officer
Anja Helena Korhonen Independent Director
Kuisma Veli-Pekka Niemelä Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORIOLA OYJ-33.41%635
RAIA DROGASIL SA44.80%8 777
PALTAC CORP79.45%2 778
AIN HOLDINGS INC-4.39%2 310
RITE AID CORPORATION-78.28%2 000
PETMED EXPRESS INC86.78%880